Filing
2nd Quarter - Report
Lobbying activity
5
Privacy legislation related to biopharmaceutical manufacturers; Food and Drug Administration issues related to biopharmaceutical manufacturers; National security issues related to biopharmaceutical manufacturers; Public-private contracts for innovation in the biopharmaceutical space.
Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers.
Intellectual property legislation related to biopharmaceutical manufacturers.
Trade and tariff issues related to corporations.
Tax and inflation issues related to corporations.